PREVALENCE OF MARKERS OF HEPATOTROPIC VIRUSES AMONG DRUG-ADDICTS IN WARSAW, POLAND

被引:14
作者
LASKUS, T [1 ]
RADKOWSKI, M [1 ]
LUPA, E [1 ]
SLUSARCZYK, J [1 ]
CIANCIARA, J [1 ]
HALAMA, G [1 ]
NOWICKA, R [1 ]
机构
[1] INST INFECT & PARASIT DIS,DEPT HEPATOL,WARSAW,POLAND
关键词
D O I
10.1016/0168-8278(92)90021-G
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We studied 100 unselected parenteral drug abusers for infection with hepatitis C, B, A and D virus (HCV, HBV, HAV and HDV). Seventy-six percent had serological evidence of HCV infection. 12% were positive for HBsAg and at least one marker of HBV infection was present in 69%. These results were significantly higher than in a matched control population. Compared to controls, the prevalence of anti-HAV (65%) was not significantly increased in drug addicts. Of the anti-HCV-positive drug addicts, 80.3% had at least one marker of HBV infection compared to 33.3% of anti-HCV-negative cases (p < 0.001). No such correlation was found between the prevalence of HCV or HBV infection markers and the presence of anti-HAV. Antibodies against HDV were detected in 16 (16%) of the samples from drug addicts. No significant association was found between antibodies to HCV and gender, age and duration of drug abuse. The risk of HBV infection increased significantly with years of drug abuse but was not associated with age and sex. The presence of anti-HAV was related to age only. Sixteen (16%) of the subjects were definitely positive for anti-HIV-1, but at the time of the study they were asymptomatic. No significant association was found between the presence of anti-HIV and the prevalence of serological markers of HBV, HCV, HAV and HDV infection.
引用
收藏
页码:114 / 117
页数:4
相关论文
共 21 条
[1]  
AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447
[2]   IMMUNOLOGICAL DYSFUNCTION IN HEROIN-ADDICTS [J].
BROWN, SM ;
STIMMEL, B ;
TAUB, RN ;
KOCHWA, S ;
ROSEFIELD, RE .
ARCHIVES OF INTERNAL MEDICINE, 1974, 134 (06) :1001-1006
[3]   ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND SUBOPTIMAL RESPONSE TO HEPATITIS-B VACCINATION [J].
COLLIER, AC ;
COREY, L ;
MURPHY, VL ;
HANDSFIELD, HH .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (02) :101-105
[4]  
ESTEBAN JI, 1989, LANCET, V2, P294
[5]   INFECTION WITH DELTA AGENT IN SWEDEN - INTRODUCTION OF A NEW HEPATITIS AGENT [J].
HANSSON, BG ;
MOESTRUP, T ;
WIDELL, A ;
NORDENFELT, E .
JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (04) :472-478
[6]   HEPATITIS-A IN YOUNG NORWEGIAN DRUG-ADDICTS AND PRISON-INMATES [J].
HOLTER, E ;
SIEBKE, JC .
INFECTION, 1988, 16 (02) :91-94
[7]   AN ASSAY FOR CIRCULATING ANTIBODIES TO A MAJOR ETIOLOGIC VIRUS OF HUMAN NON-A, NON-B-HEPATITIS [J].
KUO, G ;
CHOO, QL ;
ALTER, HJ ;
GITNICK, GL ;
REDEKER, AG ;
PURCELL, RH ;
MIYAMURA, T ;
DIENSTAG, JL ;
ALTER, MJ ;
STEVENS, CE ;
TEGTMEIER, GE ;
BONINO, F ;
COLOMBO, M ;
LEE, WS ;
KUO, C ;
BERGER, K ;
SHUSTER, JR ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :362-364
[8]   ABNORMALITIES OF B-CELL ACTIVATION AND IMMUNOREGULATION IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
LANE, HC ;
MASUR, H ;
EDGAR, LC ;
WHALEN, G ;
ROOK, AH ;
FAUCI, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (08) :453-458
[9]  
LANGE WR, 1990, ARCH INTERN MED, V150, P365, DOI 10.1001/archinte.150.2.365
[10]   AN EPIDEMIC OF HEPATITIS IN A CHRONIC-HEMODIALYSIS UNIT - AUSTRALIA ANTIGEN AND DIFFERENCES IN HOST RESPONSE [J].
LONDON, WT ;
DIFIGLIA, M ;
SUTNICK, AI ;
BLUMBERG, BS .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 281 (11) :571-&